Total Pageviews

Thursday, 1 August 2013

INTERNATIONAL CONFERENCE ON TRADITIONAL MEDICINE - Experts

Provisional List of Experts 
 
2. Prof. Chun Tao CHE (USA)
3. Dr. Elaine Elisabetsky (Brazil)
4. Dr. Peter Fisher (United Kingdom)
5. Dr. Ahmed Alkofahi (Jordan)
6. Prof. DrissaDiallo (Mali)
7. Dr. Mawuli Kofi – Tsekpo (Kenya) 
 
International Conference on Traditional Medicine for South – East Asian Countries
 

INTERNATIONAL CONFERENCE ON TRADITIONAL MEDICINE - Expected Outcomes


1. Broaden and update the knowledge on integration, regulation and research priorities in TM & CM for PHC,
2. Better comprehension on integration, regulation, use of TM & CM in PHC and evidence-based research information,
3. Generic strategic frameworks on: (a) the use of TM & CM in PHC; (b) regulation of TM & CM products, practices and providers; (C) evaluation of efficacy, safety and quality of TM & CM; and (d) clinical research of TM & CM products for PHC,
4. Enhanced cooperation among the countries of SEARO region in the field of Traditional medicine,
5. Identification of the key issues related to strengthening of Traditional medicine as a part of the National Health System.
 
 

INTERNATIONAL CONFERENCE ON TRADITIONAL MEDICINE - Specific Objectives:


1. To apprise global perspectives on TM & CM with regard to integration in National Health Systems, regulation and research priorities for PHC,
2. To share country experiences in: (a) integration of TM & CM into the National Health System; (b) regulation of TM & CM products, practices and providers; and (c) the use of TM & CM in PHC; and (d) generation of evidence-based information through research,
3. To discuss, exchange views and information to identify key issues in developing strategic frameworks on: (a) the use of TM & CM in PHC; (b) regulation of TM & CM products, practices and providers; (c) evaluation of efficacy, safety and quality of TM & CM; (d) clinical research of TM & CM products for use in PHC,
4. To expand the knowledge base required to actively manage TM & CM,
5. To enhance cooperation in the field of TM & CM among South-East Asian countries,
6. To promote equitable access to health through ap propriate integration of TM & CM services in health delivery.

INTERNATIONAL CONFERENCE ON TRADITIONAL MEDICINE - General Objectives

To promote the role of traditional and complemen
tary medicine (TM & CM) in health care provision in general and primary health care (PHC) in particular,
2. To evaluate the integration of TM & CM into Nati
onal Health Systems and promotion for their use in Primary Health Care,
3. To share research methodologies for studies on s
afety, efficacy and quality of TM & CM for PHC in order to identify best practices to ensure the safety,
quality and efficacy of such medicines,
4. To share National policies, programmes and exper
iences on TM & CM to promote and propagate them in SEARO Region, 
5. To exchange views and share evidence-based info
rmation and country experiences on TM & CM,
6. To identify priority issues and challenges in st
rengthening the development and appropriate integration of traditional medicine as part of the National Health system.

INTERNATIONAL CONFERENCE ON TRADITIONAL MEDICINE FORSOUTH - EAST ASIAN COUNTRIES

INTERNATIONAL CONFERENCE ON TRADITIONAL MEDICINE 
FORSOUTH - EAST ASIAN COUNTRIES
 
(Organized by Department of AYUSH, Ministry of Health & Family Welfare, Government of India in collaboration with WHO South-East Asia Regional Office at New Delhi, India during 12-14 Fe
bruary, 2013)
 
World Health Organization (WHO) has been supporting the development of traditional and complementary medicines (TM & CM) in all member countries. The 62nd World Health Assembly Resolution WHA62.13 in 2009, urged the Member States to undertake various activities in the field
of traditional medicine in accordance with national capacities, priorities, relevant legislations and
circumstances. The activities inter alia include strengthening communication between conventional and traditional medicine provi ders, formulating national policies, regulations and standards and cooperation among countries with regard to sharing knowledge and practices of traditional medi
cine.
 
 

Fourth WHO Working Group Meeting on Traditional Medicine Strategy

Fourth WHO Working Group Meeting on Traditional Medicine Strategy 
held in Hong Kong

The World Health Organization (WHO) today (April 24) convened the Fourth Working Group Meeting on Traditional Medicine Strategy in Hong Kong to further discuss and develop the next WHO traditional medicine global strategy.

     The three-day meeting, jointly organised by the WHO and Hong Kong's Department of Health (DH), continues to devise the next global strategy in the light of the latest global developments in traditional medicine and the challenges that have emerged in the past decade.

     Addressing the opening ceremony today, the Director of Health, Dr Constance Chan, said, "Traditional medicine has been, and will continue to be, a precious resource and part of the cultural heritage in many parts of the world. It is our mission to maximise the potential contribution of traditional medicine to the health care system to benefit our people, and our responsibility to ensure this resource is used in a safe, effective and cost-effective manner."

     "Production of the global strategy at this point in time cannot be more pertinent," she added.

     Dr Chan said that the Chinese Medicine Division of the DH, which is the designated WHO Collaborating Centre for Traditional Medicine, would continue to support the WHO to advocate and implement the global strategy, and facilitate better collaboration and co-ordination among WHO member states and regions.

     She also took the opportunity to share with participants some of the recent milestones that mark the Government's strong commitment to the development of Chinese medicine in Hong Kong. These include the setting up of the Chinese Medicine Development Committee (CMDC) by the Chief Executive early this year to give recommendations to the Government concerning the direction and long-term strategy in the future development of Chinese medicines in Hong Kong, and the publication of the fifth volume of the Hong Kong Chinese Materia Medica Standards (HKCMMS) in December last year.

     "The CMDC sets the scene for better integration of traditional medicine in the mainstream health care system, contributing to its modernisation and internationalisation, while the HKCMMS with publications up to five volumes so far, covering standards for about 200 commonly used herbs in Hong Kong, is an important step forward to ensure the quality of herbs on sale in the local market," Dr Chan said.

     Dr Chan expressed her sincere gratitude to the WHO for its leadership in co-ordinating member states and regions in formulating the global strategy, which would shape the future of health care and bring the whole world to new horizons.

     About 20 international experts from the WHO's six regions, namely Africa, the Americas, South-East Asia, Europe, the Eastern Mediterranean and the Western Pacific, as well as local experts attended the meeting.
Ends/Wednesday, April 24, 2013

Photo

WHO Department of Technical Cooperation for Essential Drugs and Traditional Medicine

Department of Technical Cooperation for Essential Drugs and 

Traditional Medicine (HTP/TCM)

The Department of Technical Cooperation for Essential Drugs and Traditional Medicine (TCM) is the lead department in WHO for technical cooperation with countries on medicines issues. Using the WHO Medicines Strategy 2004-2007 as its framework, TCM’s priority in technical collaboration is improving access and rational use of quality essential medicines, including traditional and complementary/alternative medicines.
TCM works with the the Department of Policy and Standards Of Medicines (PSM), WHO Regional and Country Offices in order to provide and coordinate relevant technical support to countries.

In response to country requests, TCM makes WHO resources and experts available for:
  • Sharing policy and technical advice
  • Advocating for and building capacity on medicines issues
  • Encouraging appropriate research and development
  • Promoting partnerships and coordination of the many parties working to improve access to medicines
  • Monitoring country pharmaceutical situations
TCM is also responsible for:
  • Regular monitoring of the impact of WHO work in medicines
  • WHO’s normative work on traditional and complementary/alternative medicines
  • WHO’s normative work on international, regional and bilateral trade agreements as they relate to access to medicines

Mission

TCM's mission is to support Member States in country, intercountry, and regional efforts to develop, implement and monitor the effectiveness of national medicines policies, guidelines, strategies and plans that ensure the availability, affordability and rational use of essential medicines and traditional and complementary/alternative medicines that are safe, effective and of good quality.

Objective

The overall objective of TCM is to contribute to improving health and saving lives by supporting countries and regions to develop, implement and monitor national policies on medicines, including traditional medicines and complementary/alternative medicines, based on:
  • Equity of access to essential medicines, traditional medicines and complementary/alternative medicines
  • Rational use of essential medicines, traditional medicines and complementary/alternative medicines
  • Quality, safety and efficacy of essential medicines, traditional medicines and complementary/alternative medicines; and that
  • Consider the context of international, regional and bilateral trade agreements.